These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1303818)

  • 1. [The value of serum tumor-associated glycoprotein 72 (TAG 72) in the diagnosis of malignancies].
    Sun G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):447-50. PubMed ID: 1303818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of the TAG-72 (CA 72-4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker].
    Zeimet AG; Guadagni F; Marth C; Amato T; Müller-Holzner E; Huter O; Daxenbichler G; Dapunt O
    Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):195-9. PubMed ID: 7789707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of TAG-72 as a serum marker in ovarian and breast carcinoma.
    Esposito G; Panza N; Mansi L; De Matteis A; D'Aiuto G; Labonia V; Riccardi F; Pacilio G; Salvatore M
    J Nucl Med Allied Sci; 1990; 34(2):88-93. PubMed ID: 2246676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary data.
    Gadducci A; Ferdeghini M; Ceccarini T; Prontera C; Facchini V; Bianchi R; Fioretti P
    J Nucl Med Allied Sci; 1989; 33(1):32-6. PubMed ID: 2746365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
    Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.
    Jacobs IJ; Oram DH; Bast RC
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):396-9. PubMed ID: 1495694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy.
    Padungsutt P; Thirapagawong C; Senapad S; Suphanit I
    Anticancer Res; 2000; 20(2B):1291-5. PubMed ID: 10810437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of the new tumor marker TAG-72.
    Guadagni F; Roselli M; Ferroni P; Amato T; Colcher D; Greiner JW; Schlom J
    Anticancer Res; 1991; 11(4):1389-94. PubMed ID: 1746895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
    Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levels of circulating tumor-associated glycoprotein (TAG-72) in patients with carcinoma using a novel tumor marker, CA 72-4].
    Ohuchi N; Matoba N; Taira Y; Takahashi K; Sakai N; Sato K; Fujita N; Mochizuki F; Nishihira T; Mori S
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2767-72. PubMed ID: 3166366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of serum TAG-72 as a tumor marker for pancreatic carcinoma. Comparison with CA 19-9.
    Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
    Int J Pancreatol; 1994 Jun; 15(3):171-7. PubMed ID: 7930777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of tumor-associated glycoprotein (TAG-72) in digestive cancers.
    Motoo Y; Satomura Y; Kawakami H; Watanabe H; Ohta H; Okai T; Sawabu N
    Oncology; 1990; 47(6):456-62. PubMed ID: 2243663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tag 72: a new tumor-associated antigen identified by a monoclonal antibody].
    Piantino P; Fusaro A; Daziano E; Polloni R; Mosso R; Cacace G
    Minerva Med; 1990 Nov; 81(11):765-7. PubMed ID: 2255410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
    Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J
    Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the tumor marker TAG-72 in head and neck neoplasms].
    Altissimi G; von Garrel C
    HNO; 1990 Oct; 38(10):364-6. PubMed ID: 2283330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
    Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
    Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A
    Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant disease.
    Filella X; Molina R; Jo J; Bedini JL; Joseph J; Ballesta AM
    Bull Cancer; 1992; 79(3):271-7. PubMed ID: 1392166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases].
    Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
    Gan To Kagaku Ryoho; 1994 May; 21(6):823-32. PubMed ID: 8185340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apocrine carcinoma, adenopathies, and raised TAG-72 serum tumor marker.
    Santos-Juanes J; Bernaldo de Quirós JF; Galache Osuna C; Sánchez del Río J; Allende MT; Folgueras MV; Soto de Delás J
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):566-9. PubMed ID: 15056154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.